Clik here to view.
PHCホールディングス株式会社：エプレディアによるLunaphoreとのLabSat Researchの独占販売にかかる契約締結について
東京 （ビジネスワイヤ） — PHCホールディングス株式会社（本社：東京都港区）の100%子会社で、精緻ながん診断・組織診断領域におけるグローバルリーダーであるEpredia（本社：米国 ニューハンプシャー州ポーツマス、以下「エプレディア」）と、がん研究における革新的な次世代機器を開発するスイスのライフサイエンス企業Lunaphore Technologies SA（本社：スイス...
View ArticleClik here to view.
Cell Therapy Tools for Cartilage Repair From Osteoarthritic Knee Joint of...
TOKYO A break through feat of growing pluripotency expressing cells from osteoarthritis (OA) affected cartilage tissue of knee joints of elderly has been reported by orthopedicians and cell culture...
View ArticleClik here to view.
Terns Pharmaceuticals Initiates the LIFT Study, a Phase 2a Clinical Trial of...
FOSTER CITY, Calif. & SHANGHAI Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat liver disease and cancer, today...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
Terns Pharmaceuticals、NASH治療に向けたTERN-101の第2a相臨床試験LIFTを開始
米カリフォルニア州フォスターシティ & 上海 （ビジネスワイヤ） — 肝疾患とがんの革新的治療薬の創薬と開発に傾注する世界的バイオ製薬会社のTerns Pharmaceuticals,...
View ArticleClik here to view.
Merck’s KEYTRUDA® (pembrolizumab) Approved in China for Second-Line Treatment...
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has been approved by the National Medical Products...
View ArticleClik here to view.
Nanox Enters Asia Pacific: Signs Strategic Agreement With Golden Vine...
NEVE ILAN, Israel & TAIPEI, Taiwan NANO-X IMAGING LTD (www.nanox.vision) (“Nanox” or the “Company”), an innovative medical imaging technology company, announces it has signed an exclusive...
View ArticleClik here to view.
EpimAb Biotherapeutics Presents Preclinical Data Characterizing EMB-01 at...
SHANGHAI EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today presented preclinical data at the 2020 American Association for...
View ArticleClik here to view.
Apyx Medical Corporation Announces Regulatory Clearance to Market and Sell...
CLEARWATER, Fla. Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the...
View ArticleClik here to view.
Sengenics Launches ImmuSAFE COVID+, the World’s First High-Throughput,...
SINGAPORE Sengenics, the Functional Proteomics Company, today announced the launch of ImmuSAFE™ COVID+, a multi-antigen, multi-domain, fully quantitative serology test. ImmuSAFE™ enables the...
View ArticleClik here to view.
DIH任命Vaseem Mahboob为执行副总裁兼首席财务官
马萨诸塞州诺韦尔 (美国商业资讯)–以通过创新和整合来转变康复护理模式为愿景的全球领先机器人和虚拟现实(VR)技术提供商DIH今天宣布，其已任命Vaseem Mahboob为公司执行副总裁兼首席财务官(CFO)，自2020年7月9日起生效。Mahboob先生还将担任DIH公司执行委员会成员。 DIH创始人、董事长兼首席执行官Jason...
View ArticleClik here to view.
joimax® Signs National Distribution Partner in Taiwan
KARLSRUHE, Germany joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new countrywide...
View ArticleClik here to view.
次世代のバイオテクノロジーパイプラインを創出すべくシリーズB資金調達で2300万カナダドルを確保
トロント （ビジネスワイヤ） — ネオバイオテクノロジー企業のサイクリカは本日、2300万カナダドルのシリーズB資金調達を完了したと発表しました。本ラウンドはドライブ・キャピタルが主導し、Chiesi Farmaceutici、グリーンスカイ・キャピタル、サイクリカ経営陣のメンバーが参加しました。...
View ArticleClik here to view.
AVROBIO Announces the Appointment of Kim Raineri as Chief Manufacturing and...
CAMBRIDGE, Mass. AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced the appointment of Kim...
View ArticleClik here to view.
Jadeja Scores Century in Partnership with Gavaskar
SANTA CLARA, Calif. Sunil Gavaskar, Legendary Indian Cricketer and Chairman, Board of Governors, Heart to Heart Foundation (H2H Foundation), has scored a century in partnership with Asha Jadeja....
View ArticleClik here to view.
GoLiver Therapeutics的急性肝功能衰竭临床开发和生物制造策略获得欧洲药品管理局(EMA)的肯定性科学建议
法国南特 (美国商业资讯)–GoLiver Therapeutics是一家专注于开发创新治疗药品的初创公司，特别是用于威胁生命的肝脏疾病的细胞疗法产品，而无需使用分化的多能干细胞移植。该公司宣布，欧洲药品管理局(EMA)对于其临床开发、药理毒理学和生产策略计划已给予肯定性科学建议。凭借该肯定性科学建议，GoLiver Therapeutics的临床路线图已达到一个重要的里程碑。...
View ArticleClik here to view.
GoLiver Therapeutics、急性肝不全に対する臨床開発およびバイオ製造戦略につき欧州医薬品庁（EMA）より肯定的な科学的勧告を受領
仏ナント （ビジネスワイヤ） — 革新的医薬品、特に分化多能性幹細胞を使用し、移植を必要とせずに、生命を脅かす肝疾患を治療する細胞治療製品の開発に傾注する新興企業のGoLiver Therapeuticsは、欧州医薬品庁（EMA）が当社の臨床開発／医薬品毒性／製造戦略計画に対する肯定的な科学的勧告を与えたと発表しました。GoLiver...
View ArticleClik here to view.
Cyclica筹集2300万加元B轮融资，用于研制未来的生物技术产品管线
多伦多 (美国商业资讯)–新兴生物技术公司Cyclica今天宣布完成2300万加元B轮融资。此轮融资由Drive Capital领投，Chiesi Farmaceutici、GreenSky Capital和Cyclica管理团队成员参投。...
View ArticleClik here to view.
Laboratory Studies Confirm the Effectiveness of BETADINE® Gargle and...
KUALA LUMPUR, Malaysia Laboratory testing completed at the Tropical Infectious Diseases Research and Education Center (TIDREC) at the University of Malaya, Malaysia, has confirmed the effectiveness...
View Article